LoginGet started
Picture of Panacea Biotec logo

PANACEABIO — Panacea Biotec Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for Panacea Biotec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line486-1,712-1,44214,488128
Depreciation
Non-Cash Items-1,2832,0301,839-14,987-1,350
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital1,291-1,062209-1,022-3,394
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities1,045-3021,067-1,084-4,225
Capital Expenditures-47.8-69.1-218-125-409
Purchase of Fixed Assets
Other Investing Cash Flow Items-5.69-278-25912,9514,713
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-53.5-348-47712,8264,303
Financing Cash Flow Items-664-451-994-3,898-36
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,011907-471-11,759-184
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-19.7258119-17.3-105